Page last updated: 2024-10-30

loxoprofen and Glomerulonephritis, Minimal Change

loxoprofen has been researched along with Glomerulonephritis, Minimal Change in 2 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanazawa, H1
Kotoda, A1
Akimoto, T1
Shinozaki, T1
Inoue, M1
Sugimoto, H1
Kusano, E1
Kikuchi, H1
Aoyagi, M1
Nagahama, K1
Yajima, Y1
Yamamura, C1
Arai, Y1
Hirasawa, S1
Aki, S1
Inaba, N1
Tanaka, H1
Tamura, T1

Other Studies

2 other studies available for loxoprofen and Glomerulonephritis, Minimal Change

ArticleYear
Serial Tc-99m MAG3 renography evaluating the recovery of acute kidney injury associated with minimal change nephrotic syndrome.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:9

    Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Susceptibility; Fracture

2013
Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:11

    Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Kidney; Neph

2014